Tyndall Capital Partners

Tyndall Capital Partners as of March 31, 2019

Portfolio Holdings for Tyndall Capital Partners

Tyndall Capital Partners holds 3 positions in its portfolio as reported in the March 2019 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Onconova Therapeutics 53.3 $2.7M 816k 3.30
Mma Capital Management 45.2 $2.3M 76k 30.28
Onconova Therapeutics Inc *w exp 07/07/202 1.5 $74k 391k 0.19